<DOC>
	<DOCNO>NCT02695862</DOCNO>
	<brief_summary>The study single center ; prospective , parallel arm randomize control trial.The patient present Institute Liver &amp; Biliary Sciences esophageal variceal bleed develop esophageal bleeding hospital stay . All patient manage continuous non-invasive cardiac hemodynamic monitoring include cardiac rhythm , pulse rate , blood pressure , oxygen saturation . Hemoglobin ( Hb ) check every 6 h initial 48 h every 12 h till discharge . Likewise , serum creatinine check daily . Packed red blood cell transfuse maintain target Hb â©¾8 g/dl . Patients start IV Proton Pump Inhibitor , bolus dose terlipressin ( 2mg ) follow Endoscopic variceal ligation . All patient receive prophylactic antibiotic ; antibiotic stop indication continue . After confirmation EVB ( Esophageal Variceal Bleeding ) successful initial hemostasis emergency EVBL ( Endoscopic Variceal Band ligation ) , patient randomly assign Group -A ( Bolus terlipressin 1mg every 4hourly ) Group-B ( Continuous infusion terlipressin @ 4mg/24hour initially ) therapy esophageal varix . They undergo HVPG ( Hepatic Venous Pressure Gradient ) measurement baseline , 12hours 24hours . Patient continuous group titrate dose . accordingly HVPG ( Hepatic Venous Pressure Gradient ) measurement 12 24 hour . At 24 hour patient direct receive either TIPS ( Transjugular Intrahepatic Portosystemic Shunt ) continue Terlipressin 48 hour .</brief_summary>
	<brief_title>To Assess Safety Efficacy Bolus Versus Continuous Infusion Terlipressin Acute Variceal Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>Any patient acute esophageal variceal bleeding ( defined Asian pacific Association study Liver Disease ) Informed consent participate study Age 18 70 year Pregnant lactation Prior treatment vasoactive drug Significant heart respiratory failure Peripheral arteriopathy clinically significant Previous heart stroke significant alteration Electrocardiogram Hemodynamically unstable Refusal participate study Hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>